These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11865137)

  • 1. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
    Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith MA; Strocchi P; Zaccheo D; Tabaton M
    Neurology; 2002 Feb; 58(4):589-92. PubMed ID: 11865137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
    Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N
    J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Blanco R; Carmona M; Ribera R; Goutan E; Puig B; Rey MJ; Cardozo A; Viñals F; Ribalta T
    Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles.
    Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E
    Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
    Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles.
    Augustinack JC; Sanders JL; Tsai LH; Hyman BT
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):557-64. PubMed ID: 12071639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
    Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy with dementia: cortical pathology.
    Bigio EH; Brown DF; White CL
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):359-64. PubMed ID: 10218631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy.
    Mori H; Nishimura M; Namba Y; Oda M
    Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.
    Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T
    Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
    Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J
    J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy.
    Dugger BN; Tu M; Murray ME; Dickson DW
    Neurosci Lett; 2011 Mar; 491(2):122-6. PubMed ID: 21236314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy.
    Zemaitaitis MO; Lee JM; Troncoso JC; Muma NA
    J Neuropathol Exp Neurol; 2000 Nov; 59(11):983-9. PubMed ID: 11089576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease.
    Probst A; Langui D; Lautenschlager C; Ulrich J; Brion JP; Anderton BH
    Acta Neuropathol; 1988; 77(1):61-8. PubMed ID: 3149122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
    Yoshida K; Hata Y; Kinoshita K; Takashima S; Tanaka K; Nishida N
    Acta Neuropathol; 2017 May; 133(5):809-823. PubMed ID: 28064358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cdk5 in the pathogenesis of Alzheimer's disease.
    Lau LF; Ahlijanian MK
    Neurosignals; 2003; 12(4-5):209-14. PubMed ID: 14673207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.